Fertility company Spermosens announces that 43 patients have so far been recruited to the ongoing clinical study with JUNO-Checked Generation 3 at the Center for Reproductive Medicine in Malmö, which is faster than planned. Recruitment is paused during the summer break and resumes in mid-August. The company reiterates its ambition to complete the study during 2026. In parallel, work continues to optimize the test's parameters and partner discussions.